Skip to main content

Table 1 Distributions of horses within treatment groups

From: Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent

Treatment group Treatment Mean age (years) Mean weight (kg) Mares (n) Geldings (n) Stallions (n) WBl (n) ThB (n) Grey (n) Non-grey (n)
A SAINT18 11.1 561 2 3 1 4 2 2 4
B SAINT18+ eqIL12 + eqIL18 10.8 589 2 3 1 5 1 2 4
C SAINT18+ eqIL12-ATG + eqIL18-ATG 10.1 548 0 5 1 4 2 2 4
D SAINT18+ eqIL12-ATG-CG + eqIL18-ATG-CG 11.3 591 2 4 0 5 1 2 4
  1. IL interleukin, −ATG nonsense DNA, −ATC-CG nonsense DNA depleted of CG, WBl warmblood, ThB thoroughbred